317 related articles for article (PubMed ID: 29101368)
1. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis.
Letouzé E; Shinde J; Renault V; Couchy G; Blanc JF; Tubacher E; Bayard Q; Bacq D; Meyer V; Semhoun J; Bioulac-Sage P; Prévôt S; Azoulay D; Paradis V; Imbeaud S; Deleuze JF; Zucman-Rossi J
Nat Commun; 2017 Nov; 8(1):1315. PubMed ID: 29101368
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
3. Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
Nault JC; Letouzé E
Semin Liver Dis; 2019 Jul; 39(3):334-340. PubMed ID: 31041788
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Schulze K; Imbeaud S; Letouzé E; Alexandrov LB; Calderaro J; Rebouissou S; Couchy G; Meiller C; Shinde J; Soysouvanh F; Calatayud AL; Pinyol R; Pelletier L; Balabaud C; Laurent A; Blanc JF; Mazzaferro V; Calvo F; Villanueva A; Nault JC; Bioulac-Sage P; Stratton MR; Llovet JM; Zucman-Rossi J
Nat Genet; 2015 May; 47(5):505-511. PubMed ID: 25822088
[TBL] [Abstract][Full Text] [Related]
5. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data.
Tao Y; Ruan J; Yeh SH; Lu X; Wang Y; Zhai W; Cai J; Ling S; Gong Q; Chong Z; Qu Z; Li Q; Liu J; Yang J; Zheng C; Zeng C; Wang HY; Zhang J; Wang SH; Hao L; Dong L; Li W; Sun M; Zou W; Yu C; Li C; Liu G; Jiang L; Xu J; Huang H; Li C; Mi S; Zhang B; Chen B; Zhao W; Hu S; Zhuang SM; Shen Y; Shi S; Brown C; White KP; Chen DS; Chen PJ; Wu CI
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12042-7. PubMed ID: 21730188
[TBL] [Abstract][Full Text] [Related]
6. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
7. Genome sequencing analysis of liver cancer for precision medicine.
Nakagawa H; Fujita M; Fujimoto A
Semin Cancer Biol; 2019 Apr; 55():120-127. PubMed ID: 29605648
[TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract][Full Text] [Related]
10. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
11. The nature of mutations induced by replication–transcription collisions.
Sankar TS; Wastuwidyaningtyas BD; Dong Y; Lewis SA; Wang JD
Nature; 2016 Jul; 535(7610):178-81. PubMed ID: 27362223
[TBL] [Abstract][Full Text] [Related]
12. A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.
Marchio A; Bertani S; Rojas Rojas T; Doimi F; Terris B; Deharo E; Dejean A; Ruiz E; Pineau P
PLoS One; 2014; 9(12):e114912. PubMed ID: 25502816
[TBL] [Abstract][Full Text] [Related]
13. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.
Guo YA; Chang MM; Huang W; Ooi WF; Xing M; Tan P; Skanderup AJ
Nat Commun; 2018 Apr; 9(1):1520. PubMed ID: 29670109
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
[TBL] [Abstract][Full Text] [Related]
15. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
Murakami Y
Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
17. A Compendium of Mutational Signatures of Environmental Agents.
Kucab JE; Zou X; Morganella S; Joel M; Nanda AS; Nagy E; Gomez C; Degasperi A; Harris R; Jackson SP; Arlt VM; Phillips DH; Nik-Zainal S
Cell; 2019 May; 177(4):821-836.e16. PubMed ID: 30982602
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
19. The topography of mutational processes in breast cancer genomes.
Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
[TBL] [Abstract][Full Text] [Related]
20. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
Hosny G; Farahat N; Tayel H; Hainaut P
Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
